Glucagon-like peptide-1 receptor signaling modifies the extent of diabetic kidney disease through dampening the receptor for advanced glycation end products–induced inflammationKarly C. Sourris, Melinda T. Coughlan, Yi Ding et al.|Kidney International|2023Cited by 121
Transactivation of RAGE mediates angiotensin-induced inflammation and atherogenesisR. J. Pickering, Merlin C. Thomas, Jonathan Golledge et al.|Journal of Clinical Investigation|2018Cited by 83
Inhibitors of Advanced Glycation End Product (AGE) Formation and AccumulationKarly C. Sourris, Karin Jandeleit‐Dahm, Anna M.D. Watson|Handbook of experimental pharmacology|2020Cited by 62
Independent of Renox, NOX5 Promotes Renal Inflammation and Fibrosis in Diabetes by Activating ROS-Sensitive PathwaysJay C. Jha, Karin Jandeleit‐Dahm|Diabetes|2022Cited by 55
Endothelial reactive oxygen-forming NADPH oxidase 5 is a possible player in diabetic aortic aneurysm but not atherosclerosisFlorence Ho, Karin Jandeleit‐Dahm|Scientific Reports|2022Cited by 18